On May 14, 2026, NetraMark Holdings Inc. (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a leading artificial intelligence company focused on revolutionizing clinical trials with AI-driven precision analytics for the pharmaceutical sector, shared a business update for the second fiscal quarter ending on March 31, 2026. The Company showcased significant achievements during this period and subsequent advancements were also discussed.